Irati Urionagüena Onaindia

Refractory lupus nephritis: national multicenter study

V. Calvo-Río, Celia González-García, Paúl Hernández Velasco, Enrique Morales Ruiz et autres

es (code pays fourni par la source)

PO:09:247 Anifrolumab in systemic lupus erythematosus with renal involvement: national multicenter registry in clinical practice

V. Calvo del Rio, C. Secada-Gómez, B. García Magallón, Deseada Palma Sanchez et autres

Objectives To evaluate the effectiveness, safety and glucocorticoids sparing potential of ANI in a multicenter, real-world cohort of Spanish patients with SLE and renal involvement.Methods Observational multicenter study of patients diagnosed with SLE (EULAR/ACR 2019 criteria), treated with ANI who presented renal …

es (code pays fourni par la source)

PO:09:246 Refractory lupus nephritis: Spanish multicenter study

V. Calvo del Rio, Carmen Secada- Gómez, Celia González-García, Paúl Hernández Velasco et autres

Objectives To study a series of refractory LN including therapy and the long-term evolution.Methods Multicenter longitudinal cohort study including refractory LN. LN was defined according to GLOSEN consensus as failure to reduce proteinuria at least >25% or worsening of proteinuria and/or renal …

es (code pays fourni par la source)

PO:11:301 Anifrolumab in systemic lupus erythematosus. spanish multicenter registry in clinical practice

Calvo-Río, C. Secada-Gómez, Adrián Martín-Gutiérrez, M Retuerto-Guerrero et autres

Objectives In patients with SLE treated with ANI in clinical practice in Spain, our aim was to assess a) the profile of patients receiving ANI b) effectiveness and c) safety.Methods Observational multicenter study of patients diagnosed with SLE (EULAR/ACR 2019 classification criteria) …

es (code pays fourni par la source)

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review

V. Calvo-Río, C. Secada-Gómez, Adrián Martín Gutiérrez, M Retuerto-Guerrero et autres

BACKGROUND: Anifrolumab is approved for adults with moderate-to-severe active systemic lupus erythematosus (SLE) based on Randomised clinical trials (RCTs). While randomised pivotal RCTs have demonstrated their efficacy and safety, real-world evidence (RWE) remains limited. OBJECTIVES: To describe the clinical characteristics, effectiveness and …

es, au, us (code pays fourni par la source)

Comment on: Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries? Reply

R Verdu, José María Pego‐Reigosa, Daniel Seoane‐Mato, Mercedes Morcillo Valle et autres

Deareditor, We would like to thank Chieh-Chun Yang et al. for their positive appraisal and comments on our work [1]. Undoubtedly, the explanations requested by them have improved the clarity of our work [2]. We collected information on the place of birth …

es (code pays fourni par la source)

Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries?

R Verdu, José María Pego‐Reigosa, Daniel Seoane‐Mato, Mercedes Morcillo Valle et autres

OBJECTIVES: Prevalence of SLE varies among studies, being influenced by study design, geographical area and ethnicity. Data about the prevalence of SLE in Spain are scarce. In the EPISER2016 study, promoted by the Spanish Society of Rheumatology, the prevalence estimate of SLE …

es (code pays fourni par la source)

Valoración del riesgo de fractura en población general en España mediante el algoritmo FRAX®: Estudio EPISER2016

Carmen Gómez‐Vaquero, Dolores Fábregas-Canales, Daniel Seoane‐Mato, Carlos Sánchez‐Piedra et autres

es (code pays fourni par la source)

Prevalence of Rheumatic Diseases in Adult Population in Spain (EPISER 2016 Study): Aims and Methodology

Daniel Seoane‐Mato, Carlos Sánchez‐Piedra, Lucía Silva-Fernández, Francisca Sivera et autres

es (code pays fourni par la source)

FRI0699 Rheumatology talks to the community: results of an educational intervention

Sandra P. Chinchilla, Joana Atxotegi, Irati Urionagüena Onaindia, Fernando Pérez-Ruiz

es (code pays fourni par la source)

Prevalencia de enfermedades reumáticas en población adulta en España (estudio EPISER 2016). Objetivos y metodología

Daniel Seoane‐Mato, Carlos Sánchez‐Piedra, Lucía Silva-Fernández, Francisca Sivera et autres

es (code pays fourni par la source)

THU0529 Impact of An Educational Program for The Management of Gout Directed To Primary Care Physicians

Sandra P. Chinchilla, Irati Urionagüena Onaindia, Fernando Pérez-Ruiz, J. Ugarriza Ortueta

es (code pays fourni par la source)